Latanoprost 拉坦前列腺素
CAS 130209-82-4 MFCD00216074
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- {SNA} Approved Therapeutics/Drug Candidates, Arachidonic Acid Cascade, Bioactive Small Molecule Alphabetical Index, Fluorination Ready Pharma-Developed Compounds, Johnson & Johnson, L, Lipids in Cell Signaling, Prostaglandins, 生物活性小分子, 细胞信号转导和神经科学, 细胞生物学
- Chiral Reagents
- Pharmaceuticals
- Intermediates & Fine Chemicals
- {SNA} Approved Therapeutics/Drug Candidates, Arachidonic Acid Cascade, Bioactive Small Molecules, Cell Biology, Cell Signaling and Neuroscience, Johnson & Johnson, L, Lipids in Cell Signaling, Prostaglandins
- Aromatics
产品应用
- Prostaglandin analog, used to treat glaucoma and other degenerative diseases of the eye.
相关文献及参考
- [2]. Zheng J, et al. Latanoprost promotes neurite outgrowth in differentiated RGC-5 cells via the PI3K-Akt-mTOR signaling pathway. Cell Mol Neurobiol. 2011 May;31(4):597-604.
- [3]. Tsai S, et al. The effect of topical latanoprost on anterior segment anatomic relationships in normal dogs. Vet Ophthalmol. 2013 Sep;16(5):370-6.
- [4]. Ooi YH, et al. Effect of bimatoprost, latanoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human ciliary body smooth muscle cells. Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5259-65.
- [5]. B'Ann True Gabelt, et al. Prostaglandin Subtype-Selective and Non-Selective IOP-Lowering Comparison in Monkeys.
- Hernandez, M., et al.: Exp. Eye Res., 86, 798 (2008),
- Nagata, T., et al.: J. Pharmacol. Sci., 106, 423 (2008),
- Rhee, D.J., et al.: Clinic. Ophthalmol., 2, 313 (2008),
- [1]. Pauly A, et al. In vitro and in vivo comparative toxicological study of a new preservative-free latan
安全信息
GHS Symbol
- P264 Wash hands thoroughly after handling. 处理后要彻底洗净双手。
- P301+P310
- H300 Fatal if swallowed 吞食致命